Friday, 17 Aug 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Philip Robinson at EULAR 2018 on...

20 Jun 2018

The RheumNow Week in Review – 28 July...

28 Jul 2017

Dr. Cush Heads to San Francisco

06 Nov 2015

The RheumNow Week in Review – No Good...

10 Aug 2018

Dr. Ronan Kavanagh: The greatest...

14 Nov 2016

The RheumNow Week in Review - 16 March...

16 Mar 2018

RheumNow (ACR16) Week in Review – 18...

18 Nov 2016

Dr. Ronan Kavanagh at EULAR 2018 on...

20 Jun 2018

Dr. Julie Jones: Sporadic Late Onset...

02 Mar 2016

Dr. Janet Pope: Pre-op for Total Hip or...

07 Nov 2017

The RheumNow Week in Review – 28...

28 Oct 2016

RheumNow Week in Review – 23 September...

26 Sep 2016